Results 121 to 130 of about 106,090 (294)

Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community setting [PDF]

, 1998
Edward F. Philbin
openalex   +1 more source

Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? [PDF]

, 2020
Jeffrey M. Turner, Ravi Kodali
openalex   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice. [PDF]

Sci Rep, 2023
Ito A, Ohnuki Y, Suita K, Matsuo I, Ishikawa M, Mitsubayashi T, Mototani Y, Kiyomoto K, Tsunoda M, Morii A, Nariyama M, Hayakawa Y, Tomonari H, Okumura S.   +13 more
europepmc   +1 more source

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers

, 2020
Ankur Kalra, Edward S. Hawkins, Amy S. Nowacki, Vardhmaan Jain, Alex Milinovich, Joshua Saef, George Thomas, Surafel Gebreselassie, Sadashiva S. Karnik, Lara Jehi, James B. Young, Lars G. Svensson, Mina K. Chung, Neil Mehta   +13 more
openalex   +2 more sources

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Life-threatening bronchospasm induced by an angiotensin-converting enzyme inhibitor in a chronically ventilated patient: Diagnostic pitfalls and literature review. [PDF]

Respirol Case Rep, 2023
Marcus EL, Hush A, Atrash H, Shibli R, Heyman SN.   +4 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study.

, 2020
Han Lin Hsu, Chih‐Hsin Lee, Chien-Hsin Chen, Jun Fu Zhan, Szu‐Yuan Wu   +4 more
openalex   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options. [PDF]

Cureus, 2023
Ameer MA, Mushtaq J, Chaudhry H, Patel N, Khan SI.   +4 more
europepmc   +1 more source